NPI: 1790326171 · AUSTIN, TX 78723 · Federally Qualified Health Center (FQHC) · NPI assigned 10/07/2019
Authorized official SLOAN, JOY controls 19+ related entities in our dataset. Read more
| Authorized Official | SLOAN, JOY (CFO) |
| NPI Enumeration Date | 10/07/2019 |
Other providers sharing the same authorized official: SLOAN, JOY
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 5,457 | $368K |
| 2020 | 34,424 | $2.15M |
| 2021 | 102,437 | $6.03M |
| 2022 | 111,108 | $6.89M |
| 2023 | 95,858 | $6.66M |
| 2024 | 94,406 | $6.62M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 80,120 | 65,368 | $17.23M |
| D0999 | Unspecified diagnostic procedure, by report | 17,740 | 17,067 | $4.47M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 17,911 | 4,904 | $1.61M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8,696 | 2,613 | $813K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18,821 | 17,068 | $712K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22,968 | 20,630 | $646K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8,436 | 8,120 | $571K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6,674 | 6,442 | $535K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7,743 | 7,449 | $463K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,813 | 6,564 | $380K |
| 87428 | 10,852 | 10,046 | $291K | |
| 99381 | 1,627 | 1,565 | $218K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,362 | 491 | $106K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 11,496 | 10,758 | $82K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13,047 | 5,963 | $57K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,842 | 2,710 | $55K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2,404 | 2,253 | $51K |
| 90832 | Psychotherapy, 30 minutes with patient | 1,264 | 1,039 | $50K |
| S9152 | Speech therapy, re-evaluation | 466 | 441 | $50K |
| 99384 | 619 | 603 | $47K | |
| 92523 | 276 | 255 | $41K | |
| 99383 | 599 | 578 | $38K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,717 | 2,486 | $24K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 342 | 319 | $24K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,826 | 4,113 | $20K |
| 0071A | 584 | 564 | $16K | |
| 90461 | 2,923 | 2,191 | $10K | |
| 0072A | 240 | 237 | $8K | |
| 99382 | 149 | 149 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 16,847 | 16,279 | $7K |
| 0051A | 179 | 169 | $5K | |
| D1120 | Prophylaxis - child | 9,653 | 9,462 | $5K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 200 | 199 | $4K |
| 0001A | 477 | 431 | $4K | |
| 0054A | 129 | 118 | $4K | |
| 90620 | 2,331 | 2,236 | $4K | |
| D0120 | Periodic oral evaluation - established patient | 9,269 | 9,082 | $4K |
| 81002 | 2,152 | 2,022 | $4K | |
| 96160 | 2,161 | 2,121 | $3K | |
| 99429 | 121 | 120 | $3K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 298 | 293 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 756 | 743 | $3K |
| 0052A | 78 | 74 | $3K | |
| 90480 | 158 | 158 | $3K | |
| 97168 | 25 | 25 | $3K | |
| 0002A | 210 | 194 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 52 | 37 | $2K |
| 96380 | 325 | 319 | $2K | |
| D1206 | Topical application of fluoride varnish | 11,111 | 10,900 | $2K |
| D0145 | Oral evaluation for a patient under three years of age | 3,255 | 3,178 | $2K |
| 0124A | 46 | 46 | $2K | |
| D0272 | Bitewings - two radiographic images | 5,551 | 5,440 | $2K |
| D1351 | Sealant - per tooth | 7,893 | 1,667 | $1K |
| D0240 | 12,994 | 6,325 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 17,975 | 9,378 | $1K |
| 0081A | 40 | 36 | $1K | |
| D1110 | Prophylaxis - adult | 1,868 | 1,833 | $823.20 |
| 90619 | 1,481 | 1,443 | $822.47 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13 | 13 | $800.00 |
| 97161 | 16 | 15 | $697.14 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 196 | 189 | $654.51 |
| 81025 | 137 | 131 | $522.41 | |
| D0274 | Bitewings - four radiographic images | 1,287 | 1,269 | $484.54 |
| 96158 | 110 | 90 | $431.98 | |
| 92551 | 1,470 | 1,429 | $177.91 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 120 | 107 | $124.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 13 | 13 | $119.60 |
| 90474 | 1,788 | 1,739 | $105.30 | |
| D0220 | Intraoral - periapical first radiographic image | 466 | 446 | $87.92 |
| J3535 | Drug administered through a metered dose inhaler | 21 | 19 | $42.00 |
| D0140 | Limited oral evaluation - problem focused | 195 | 193 | $37.56 |
| D0150 | Comprehensive oral evaluation - new or established patient | 804 | 787 | $35.32 |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 553 | 522 | $27.11 |
| A9150 | Non-prescription drugs | 37 | 37 | $20.50 |
| 81003 | 148 | 144 | $15.51 | |
| 90686 | 10,281 | 9,955 | $7.61 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 20 | 19 | $7.58 |
| D0603 | 11,227 | 11,025 | $0.02 | |
| D0601 | 787 | 782 | $0.02 | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 34 | 31 | $0.01 |
| 90651 | 3,776 | 3,662 | $0.00 | |
| 91307 | 1,004 | 935 | $0.00 | |
| 90696 | 1,179 | 1,140 | $0.00 | |
| 90723 | 2,871 | 2,795 | $0.00 | |
| 90744 | 1,203 | 1,167 | $0.00 | |
| 90698 | 1,918 | 1,853 | $0.00 | |
| D0602 | 1,788 | 1,746 | $0.00 | |
| 96161 | 15 | 13 | $0.00 | |
| 90677 | 1,395 | 1,347 | $0.00 | |
| 90716 | 1,505 | 1,453 | $0.00 | |
| 90381 | 211 | 206 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 1,428 | 1,411 | $0.00 |
| 91305 | 650 | 590 | $0.00 | |
| 36416 | 439 | 413 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 221 | 217 | $0.00 |
| 90656 | 998 | 995 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 32 | 32 | $0.00 |
| D0210 | Intraoral - complete series of radiographic images | 30 | 30 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 84 | 77 | $0.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 172 | 121 | $0.00 |
| D1208 | Topical application of fluoride, excluding varnish | 142 | 136 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 17 | 17 | $0.00 |
| D7140 | Extraction, erupted tooth or exposed root | 29 | 24 | $0.00 |
| 91319 | 25 | 25 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 15 | 15 | $0.00 |
| 90633 | 3,295 | 3,179 | $0.00 | |
| 99173 | 2,334 | 2,275 | $0.00 | |
| 90681 | 2,874 | 2,787 | $0.00 | |
| 90648 | 4,039 | 3,925 | $0.00 | |
| 90710 | 1,272 | 1,230 | $0.00 | |
| 90734 | 1,719 | 1,650 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 1,580 | 1,549 | $0.00 |
| 90670 | 3,395 | 3,268 | $0.00 | |
| 90700 | 1,115 | 1,088 | $0.00 | |
| 90671 | 1,371 | 1,360 | $0.00 | |
| 90715 | 1,804 | 1,752 | $0.00 | |
| 91300 | 739 | 647 | $0.00 | |
| D1354 | 1,930 | 517 | $0.00 | |
| 90707 | 1,421 | 1,371 | $0.00 | |
| 91320 | 26 | 26 | $0.00 | |
| 99080 | 27 | 18 | $0.00 | |
| 91308 | 81 | 71 | $0.00 | |
| 91312 | 46 | 46 | $0.00 | |
| 90649 | 225 | 222 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 57 | 51 | $0.00 |
| 90655 | 53 | 53 | $0.00 | |
| D9910 | 87 | 17 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 42 | 39 | $0.00 |
| 90380 | 83 | 80 | $0.00 | |
| 94664 | 13 | 13 | $0.00 |